๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer and its relations to the micrometastasis in peripheral blood

โœ Scribed by Yang Jin; Xianzhi Xiong; Yuan Su; Jianwu Hu; Xiaonan Tao

Book ID
107405969
Publisher
Springer-Verlag
Year
2009
Tongue
Chinese
Weight
295 KB
Volume
29
Category
Article
ISSN
0510-9752

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Total cyclooxygenase-2 mRNA levels corre
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients
โœ Ang Yuan; Chong-Jen Yu; Chia-Tung Shun; Kwen-Tay Luh; Sow-Hsong Kuo; Yung-Chie L ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 714 KB

## Abstract Interaction between cancer cells and adjacent stromal cells is important to promote tumor development. Our aim was to study total COXโ€2 mRNA expression in both cancer cells and surrounding stromal cells and its association with angiogenic factor VEGF mRNA expression, tumor angiogenesis

High pre-treatment serum level of vascul
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
โœ Petri Salven; Tarja Ruotsalainen; Karin Mattson; Heikki Joensuu ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 68 KB ๐Ÿ‘ 2 views

Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and vascular permeability. Increased serum VEGF concentrations (S-VEGF) have been found in patients with various types of human cancer, including cancer of the lung. However, the clinical and prognostic significance

Reaction of plasma hepatocyte growth fac
Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs
โœ Hidenori Tanaka; Tatsuo Kimura; Shinzoh Kudoh; Shigeki Mitsuoka; Tetsuya Watanab ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 242 KB

## Abstract Hepatocyte growth factor induces resistance to epidermal growth factor receptor tyrosine kinase inhibitors. It has been hypothesized that epidermal growth factor receptor tyrosine kinase inhibitors administration may influence the levels of plasma hepatocyte growth factor. Patients with